Papers

3

Total Citations

45

H-Index

2

About

Dr. Hanlin Fu is a gynecologic oncology surgeon whose research focuses on advancing minimally invasive surgical techniques for the treatment of gynecologic malignancies. Dr. Fu’s most impactful work centers on comparing the survival outcomes of robotic-assisted laparoscopy (RALS) against conventional laparoscopy and laparotomy for endometrial cancer. This highly cited meta-analysis (41 citations) provides critical evidence on the oncologic safety and efficacy of robotic surgery, helping to clarify its role in a rapidly evolving field. Beyond endometrial cancer, Dr. Fu has made significant contributions to the surgical management of rare and complex conditions, including female primary pelvic retroperitoneal tumors, where a retrospective study of 99 patients from a single Chinese center demonstrated the growing application of minimally invasive approaches. Dr. Fu is also pioneering research on robotic-assisted vaginectomy for vaginal high-grade squamous intraepithelial lesions, exploring whether this advanced technique offers superior outcomes over conventional laparoscopic surgery. Through these investigations, Dr. Fu is actively shaping the evidence base for robotic surgery in gynecologic oncology, with a clear commitment to improving patient outcomes through technological innovation and rigorous clinical evaluation.

Research Focus

Key Achievements

2
H-Index
3
Papers
45
Total Citations
15
Avg Citations/Paper
🏆 Most Cited Paper
Survival outcomes of robotic-assisted laparoscopy versus conventional laparoscopy and laparotomy for endometrial cancer: A systematic review and meta-analysis
41 citations · 2023
📈 Most Prolific Year: 2023 (2 Papers)
🤝 Key Collaborators: 15
🏛 Institutions: First Affiliated Hospital of Zhengzhou University

Top Papers

  1. 1
  2. 2
  3. 3

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago